T-Cell Immune Checkpoint Inhibition Plus Hypomethylation for Locally Advanced
HER2-Negative Breast Cancer A Phase 2 Neoadjuvant Window Trial of Pembrolizumab and Decitabine Followed by Standard Neoadjuvant Chemotherapy

IRB/UVA Tracking #
21855
Contact
Olena Glushakova
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Patrick M Dillon
Status
OPEN TO ACCRUAL
Ages
Adult